Parallax Volatility Advisers’s VanEck Biotech ETF BBH Stock Holding History

Parallax Volatility Advisers’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1	Closed	–	–	2327
2019 Q2	$0	Hold	1	–	–	﹤0.01%	2561
2019 Q1	$0	Hold	1	–	–	﹤0.01%	2770
2018 Q4	$0	Hold	1	–	–	﹤0.01%	2915
2018 Q3	$0	Hold	1	–	–	﹤0.01%	2578
2018 Q2	$0	Hold	1	–	–	﹤0.01%	2116
2018 Q1	$0	Hold	1	–	–	﹤0.01%	2284
2017 Q4	$0	Hold	1	–	–	﹤0.01%	3951
2017 Q3	$0	Hold	1	–	–	﹤0.01%	2089
2017 Q2	$0	Hold	1	–	–	﹤0.01%	2278
2017 Q1	$0	Hold	1	–	–	﹤0.01%	3542
2016 Q4	$0	Hold	1	–	–	﹤0.01%	3046
2016 Q3	$0	Hold	1	–	–	﹤0.01%	2867
2016 Q2	$0	Hold	1	–	–	﹤0.01%	2504
2016 Q1	$0	Hold	1	–	–	﹤0.01%	2500
2015 Q4	$0	Hold	1	–	–	﹤0.01%	2866
2015 Q3	$0	Hold	1	–	–	﹤0.01%	2853
2015 Q2	$0	Hold	1	–	–	﹤0.01%	3603
2015 Q1	$0	Hold	1	–	–	﹤0.01%	4375
2014 Q4	$0	Buy	+1	New	+$113	﹤0.01%	4999

Other funds holding BBH

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

BRM

Boston Research & Management Manchester, Massachusetts $421M AUM 16.18% 1-Year Est. Return

Parallax Volatility Advisers's BBH Position: Q3 2019 in Review

Parallax Volatility Advisers sold out of VanEck Biotech ETF (BBH) in Q3 2019, closing a stake of 1 share.

Parallax Volatility Advisers first reported a position in BBH in Q4 2014 and held it in 19 quarters. The position peaked at $0 in Q2 2019. 78 funds tracked by Wall St. Rank hold BBH as of Q3 2019.

Parallax Volatility Advisers reported no remaining VanEck Biotech ETF position as of Q3 2019 after selling out during the quarter.
Parallax Volatility Advisers sold 1 VanEck Biotech ETF share in Q3 2019.
Parallax Volatility Advisers first reported a position in VanEck Biotech ETF in Q4 2014 and held it in 19 quarters.
Parallax Volatility Advisers's VanEck Biotech ETF position peaked at $0 in Q2 2019.
78 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2019.

Based on Parallax Volatility Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.